Metropolitan Life Insurance CO Athersys, Inc Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$0.85 - $1.4 $49,754 - $81,949
-58,535 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$1.33 - $1.77 $77,851 - $103,606
58,535 New
58,535 $77,000
Q3 2021

Mar 30, 2023
BUY
$1.33 - $1.77 $13,313 - $17,717
10,010 Added 20.63%
58,535 $77,000
Q3 2021

Nov 15, 2021
BUY
$1.33 - $1.77 $77,851 - $103,606
58,535 New
58,535 $78,000
Q1 2021

May 14, 2021
SELL
$1.61 - $2.77 $78,125 - $134,414
-48,525 Closed
0 $0
Q4 2020

Jun 22, 2023
BUY
$1.55 - $2.24 $75,213 - $108,696
48,525 New
48,525 $84,000
Q4 2020

Mar 30, 2023
SELL
$1.55 - $2.24 $11,983 - $17,317
-7,731 Reduced 13.74%
48,525 $84,000
Q4 2020

Feb 16, 2021
SELL
$1.55 - $2.24 $11,983 - $17,317
-7,731 Reduced 13.74%
48,525 $85,000
Q3 2020

Jun 26, 2023
BUY
$1.91 - $3.08 $107,448 - $173,268
56,256 New
56,256 $109,000
Q3 2020

Mar 30, 2023
SELL
$1.91 - $3.08 $494 - $797
-259 Reduced 0.46%
56,256 $109,000
Q3 2020

Nov 13, 2020
SELL
$1.91 - $3.08 $494 - $797
-259 Reduced 0.46%
56,256 $110,000
Q2 2020

Jun 26, 2023
BUY
$1.97 - $3.98 $111,334 - $224,929
56,515 New
56,515 $155,000
Q2 2020

Mar 30, 2023
BUY
$1.97 - $3.98 $21,421 - $43,278
10,874 Added 23.83%
56,515 $155,000
Q2 2020

Aug 14, 2020
BUY
$1.97 - $3.98 $21,421 - $43,278
10,874 Added 23.83%
56,515 $156,000
Q1 2020

Jul 12, 2023
BUY
$1.17 - $3.0 $53,399 - $136,923
45,641 New
45,641 $136,000
Q1 2020

Mar 30, 2023
BUY
$1.17 - $3.0 $53,399 - $136,923
45,641 New
45,641 $136,000
Q1 2020

May 15, 2020
BUY
$1.17 - $3.0 $53,399 - $136,923
45,641 New
45,641 $137,000
Q4 2017

Feb 15, 2018
SELL
$1.65 - $2.45 $129,133 - $191,744
-78,263 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$1.5 - $2.55 $117,394 - $199,570
78,263
78,263 $161,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email